Shaping The Future Of Healthcare

Share

Impact of COVID-19 in Hospitals with Alexander Norbash, MD | Christoph Zindel

Season 1, Ep. 1

The current pandemic has made hospitals ground zero across the globe. If we haven’t personally been admitted into hospital by the virus, we can easily imagine scenes of medical staff rushing through crowded corridors, shuffling past one another, concealed head to toe in blue PPE anonymity. At some point over the past three months, this has been the daily reality in every hospital. <br>

<br>

How are hospitals managing during this unprecedented crisis? These are facilities well accustomed to “life or death” situations, but during a pandemic, downtime is a luxury that may never come. Yet, hospitals remain places of business that require management. Particularly in times of crisis, faculty need motivation to push on, and good leadership is more important than ever. University hospitals have the added challenge of overseeing a student population. Today, we’re getting a glimpse of what this crisis has been like from inside one of the top ranked University hospitals in the world. 

Our guest is Alexander Norbash, MD, an Interventional Neuroradiologist from the University of California, San Diego, where he is the Chair and Professor of Radiology, and the Associate Vice Chancellor. There, his focus is on arteriovenous vascular malformations and intracranial aneurysms, and he was among the first clinician-interventionalists to develop and describe the technology of stenting for the carotid and intracranial arteries. Dr. Christoph Zindel is Member of the Managing Board of Siemens Healthineers and holds a Doctor of Medicine M.D.

SOME QUESTIONS WE ASK:

  • How is the current situation affecting you? (3:40)
  • How do you deal with this crisis on the University level? (6:01)
  • Do you have a crisis management process in place for these situations? (10:18)
  • How are you preparing for patients coming back?(16:31)
  • How is the pandemic shaping your research? (22:57)
  • What can healthcare learn from this pandemic? (31:05)

IN THIS EPISODE, YOU WILL LEARN:

  • How people find opportunity during times of crisis (2:23)  
  • How the crisis has affected the University financially (8:12)
  • How to keep people motivated and morale high/ or The Importance of Gratitude (13:31)
  • The biggest current challenge facing this border region (20:44)
  • How diversity and inclusion are being addressed (tele-visits can be an equalizer) (27:13)

Learn more about Alexander Norbash, MD:

UCSD Profile: https://profiles.ucsd.edu/alexander.norbash

Publications: https://www.pubfacts.com/author/Alexander+Norbash

Scholar Citations: https://scholar.google.com/citations?user=rQYPnAcAAAAJ&hl=en

Head Injury Institute: http://www.headinjuryinstitute.org/about-us/leadership/alexander-norbash-md-mhcm-facr/

More Episodes

5/5/2021

How Do Coronavirus Variants Affect our Immune System, and How Can We Protect our Vulnerable?

Season 1, Ep. 12
We’ve come a long way in our understanding of SARS-CoV-2. Since the first cases were reported in late 2019, the rapid spread of the virus required quick thinking, thorough communication across the globe, and immediate action within the medical community. SARS-CoV-2 spread rapidly and began mutating differently all over the world. Tracking, testing, and treatment options had to keep pace. We needed information quickly in order to treat people effectively and protect our most vulnerable.Today, Siemens Healthineers President of Laboratory Diagnostics, Deepak Nath is joined by Dr. Ankur Mutreja, a global health scientist from the University of Cambridge, and Dr. Kevin Latinis, a clinical Rheumatologist with a practice in Missouri. Their experiences throughout the SARS-CoV-2 outbreak will help us understand how the virus continues to mutate globally, why viruses mutate, and how early antibody testing helped us to understand the ability of this virus to spread at such an advanced pace.In this episode, you’ll hear about the known variants of SARS-CoV-2, how our immune systems respond through these mutations, and why names matter. We’ll also rewind back to the beginning of the pandemic and hear about some of the earliest serology tests that took place in a Missouri nursing home, and how that timely information helped us understand how the virus spread.Some Questions Asked:What consequences can naming variants after countries or regions have? (2:09)Could a new variant emerge that effectively sets us back to square one? (4:14)How can vaccine development keep pace with these variants? (9:13)Why use antibody tests? (15:18)How can we take care of our most vulnerable? (19:49)What are the next steps for data collection? (22:39)What You’ll Learn in This Episode:Why new variants of the virus continue to be discovered (2:59)Protection levels against new variants from antibodies and the vaccine (4:54)Why mutations occur and when we need to be concerned about them (5:51)What we learned from an early study of antibodies (14:23)How antibody tests work, and what they can tell us (17:30)How one doctor is helping patients feel comfortable with vaccines (21:02)Connect with Ankur Mutreja:LinkedInConnect with Kevin Latinis:LinkedInYoutubeConnect with Katherine Soreng:LinkedInConnect with Deepak Nath:LinkedInTwitter
4/14/2021

Prioritizing Diversity and Inclusion for a Better Workplace with Prof. Dr. Ulrike Attenberger| Christoph Zindel

Season 1, Ep. 11
Diversity and inclusion are big topics in business today. While it’s something many organizations are striving for, it’s not always understood on a statistical or emotional level. When employees don’t feel as though they’re part of the team, the consequences can mount up to something much bigger. Feeling “apart” takes a toll on not only performance, but also the health of the employee. Likewise, a lack of diversity means a lack of varied experience. This can hold the whole team back, and foster a lack of understanding.Healthcare bears a unique responsibility when it comes to fostering an environment of comfort and consideration. Understanding the needs of patients is much more than tending to wounds and performing surgeries. At its core, it’s about empathy. When empathy and understanding exist within the work environment, only then can they effectively translate to the realm of care.In this episode, Managing Board Member Christoph Zindel interviews Prof. Dr. Ulrike Attenberger. Professor Attenberger is Director of the Clinic for Diagnostic and Interventional Radiology at Bonn University Hospital in Germany, and a member of the Diversity @ DRG Commission. Her interest in gender diversity led to her contribution to a 2018 special report entitled “Women in radiology: gender diversity is not a metric—it is a tool for excellence”, published by European Radiology.In today’s conversation, you’ll hear about the positive influence of a diverse workforce within the healthcare sector. Professor Attenberger believes that diversity allows us to embrace dimensionality, and shares how this reflects positively in the workplace. She also reveals the ways in which inclusivity can be achieved through organizational reforms, and how it has the capacity to benefit physicians as well as patients.Some Questions Asked:What is diversity and inclusion for you? (2:15)How should physicians take diversity into account in their work and training? (10:46)What can be done to increase the representation of women in leadership? (15:22)How do you foster inclusion at the University Hospital in Bonn, and in medicine as a whole? (22:38)What You’ll Learn in This Episode:The dangers of homogeneous healthcare (4:49)The most important aspect of building a successful team (7:35)What we know about unconscious bias (13:23)Ideas about how we can close the gap on gender-based career obstacles (19:25)Connect with Ulrike Attenberger:University Hospital BonnConnect with our Managing Board Member, Christoph Zindel:LinkedIn
3/24/2021

Understanding Immunity: How Antibody Testing for SARS-CoV-2 Works and What We Can Learn from it with Dr. Angela Rasmussen and the Mizzou Antibody Testing Team | Deepak Nath

Season 1, Ep. 10
It’s just over one year since COVID-19 became a familiar term around the world. Due to quick action and collaborative innovation from science and medicine, vaccines have been developed and are being distributed at a pace unrivaled in human history. But, the work doesn’t stop there.Regularly monitoring vaccine efficacy and surveying human behavior among the vaccinated population are crucial to understanding its durability. Antibody testing will continue to be important, long after vaccines have been administered.Our guest today is Dr. Angela Rasmussen, a virologist and affiliate of the Georgetown Center for Global Health, Science and Security. She collects evidence about the human response to emerging viruses to gain a better understanding of vaccine efficacy.Today we’re discussing all aspects of antibody testing for SARS-CoV-2. We’ll learn how the tests are implemented, how they determine an immune response is present, and why testing for antibodies is such an important part of the battle against this virus.We’ll also hear from University of Missouri (MU) scientists Dr. Mark Daniels, Professor of Immunology, Dr. John R. Middleton, Professor of Livestock Health, and Dr. Enid Schatz, chair of the Department of Public Health. The university is conducting an antibody testing study – both biological and behavioral – and our experts on the ground at MU will walk us through the antibody testing process from start to finish.Some Questions Asked:How can testing help us continue to research and improve vaccine use alongside their distribution? (2:42)What does an ideal testing scenario look like? (4:21)Which behaviors can be more easily changed, and which might be more challenging to shift? (12:13)When do you think people can expect to return to business as usual? (16:19)What You’ll Learn in This Episode:Why it’s hard to determine post-vaccination behavior recommendations (1:30)The importance of following the progress of vaccinated individuals (3:26)How antibody testing works at the University of Missouri (6:56)What we can learn from collecting behavioral data (10:27)Discoveries that were made about antibody levels (13:58)Why it’s important to invest in research now (18:51)Learn more about Dr. Angela Rasmussen:WebsiteTwitterLearn more about Dr. Mark DanielsMU School of MedicineLinkedInLearn more about Dr. John R. MiddletonMU College of Veterinary MedicineLearn more about Dr. Enid Schatz:MU School of Health ProfessionsLinkedInConnect with President of Laboratory Diagnostics, Deepak Nath:LinkedInTwitter